European Journal of Cancer
Volume 37, Issue 3 , Pages 398-401 , February 2001

Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer

Received 15 May 2000 ,Revised 7 September 2000 ,Accepted 31 October 2000.

References 

  1. Nakama H, Kamijo N. Accuracy of the immunological fecal occult blood testing for colorectal cancer screening. Prev. Med. 1994;23:309–313
  2. Nakama H. A study on the efficacy of a screening program for colorectal cancer in a small Japanese village. Clin. Investig. 1994;72:117–121
  3. Iida Y, Munemoto Y, Miura S, et al.  Clinicopathologic studies of immunologic fecal occult blood test for colorectal cancer. J. Gastroenterol. 1995;30:195–200
  4. Fattah ASMA, Nakama H, Kamijo N, Fujimori K, Zhang B. Colorectal adenomatous polyps detected by immunochemical occult blood screening. Hepatogastroenterology. 1998;45:712–716
  5. Nakama H, Kamijo N, Fattah ASMA, Zhang B. Immunochemical detection of fecal occult blood from upper digestive tract diseases. Hepatogastroenterology. 1998;45:752–754
  6. Nakama H, Kamijo N, Miyata K, Fattah ASMA, Zhang B, Uehara Y. Sensitivity and specificity of several immunochemical tests for colorectal cancer screening. Hepatogastroenterology. 1998;45:1579–1582
  7. Nakama H, Yamamoto M, Kamijo N, Fattah ASMA, Zhang B. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology. 1999;46:228–231
  8. Allison JE, Tekawa IS, Ranson LJ, et al.  A comparison of fecal occult-blood tests for colorectal-cancer screening. N. Engl. J. Med. 1996;334:155–159
  9. Mandel JS, Bond JH, Church TR, et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Med. 1993;328:1365–1371
  10. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471
  11. Hardcastle JD, Chamberlain JO, Robinson MHE, et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1147–1472
  12. Nakama H, Zhang B, Fattah ASMA. A cost-effectiveness analysis of the optimum number of stool specimens collected for immunochemical occult blood screening for colorectal cancer screening. Eur. J. Cancer. 2000;36:647–650
  13. Simon JB. Occult blood screening for colorectal cancer: a critical review. Gastroenterology. 1985;88:820–837
  14. Rogge JD, Elmore MF, Mahoney SJ, et al.  Low-cost, office-based, screening colonoscopy. Am. J. Gastroenterol. 1994;89:1775–1780
  15. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology. 1995;109:1781–1790
  16. Provenzale D, Lipscomb J. A reader's guide to economic analysis in the GI literature. Am. J. Gastroenterol. 1996;91:2461–2470
  17. Tsuji I, Fukao A, Shoji T, Kuwajima I, Sugawara N, Hisamichi S. Cost-effectiveness analysis of screening for colorectal cancer in Japan. Tohoku J. Exp. Med. 1991;164:269–378
  18. Shimbo T, Glick HA, Eisenberg JM. Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan. Int. J. Technol. Assess Health Care. 1994;10:359–375

PII: S0959-8049(00)00387-7

European Journal of Cancer
Volume 37, Issue 3 , Pages 398-401 , February 2001

Article Tools